Antibody discovery may aid new vaccines, therapies to fight influenza
HQ Team March 3, 2024: Antibodies to target a hard-to-spot region or the “dark side” of the influenza virus were discovered by researchers,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team March 3, 2024: Antibodies to target a hard-to-spot region or the “dark side” of the influenza virus were discovered by researchers,.
HQ Team May 10, 2023: Novavax, a COVID-19 vaccine maker, will lay off a quarter of its workforce and announced a global restructuring.
HQ Team April 27, 2023: Global deaths due to COVID-19 have fallen by 95% since January, and nations need to take steps to.
HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk.
An mRNA vaccine has been found to be effective against all 20 known strains of influenza A and B in animal models
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
Recurring global deadly disease outbreaks crippling economies